Bhaskar C Kolla Manish R Patel
10.1186/s40425-016-0185-2
J Immunother Cancer
2016 Nov 15;4:80.
immune related adverse effects immunotherapy lung cancer nivolumab pericardial effusion pericardial tamponade recurrent pleural effusions
CC BY
https://pubmed.ncbi.nlm.nih.gov/27895919/
Antibodies, Monoclonal / adverse effects Antineoplastic Agents, Immunological / adverse effects Cardiac Tamponade / diagnosis Cardiac Tamponade / etiology Neoplasms / complications Pleural Effusion / diagnosis Pleural Effusion / etiology
Antibodies, Monoclonal / adverse effects Antineoplastic Agents, Immunological / adverse effects Cardiac Tamponade / diagnosis Cardiac Tamponade / etiology Neoplasms / complications Pleural Effusion / diagnosis Pleural Effusion / etiology Case Reports Antibodies, Monoclonal / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Biopsy Female Humans Male Middle Aged Molecular Targeted Therapy / adverse effects Neoplasms / diagnosis Neoplasms / drug therapy Nivolumab Pericardial Effusion / diagnosis Pericardial Effusion / etiology Positron Emission Tomography Computed Tomography Recurrence Antibodies, Monoclonal Antineoplastic Agents, Immunological Nivolumab
PMC5109681
27895919
Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy- a report of two cases
2016